MicroRNAs (miRs) are promising diagnostic, prognostic and therapeutic biomolecules for
atherosclerotic cardiovascular disease. Atherosclerotic occlusive disease concerns a large …

Atherosclerosis is a multifactorial inflammatory disease characterized by the development of
plaque formation leading to occlusion of the vessel and hypoxia of the tissue supplied by the …

Cardiovascular diseases (CVDs) are the leading cause of premature morbidity and mortality
globally. The identification of novel risk factors contributing to CVD onset and progression …

Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality
worldwide. Several cardiovascular risk factors are implicated in atherosclerotic plaque …

Atherosclerosis is an underlying pathology of many vascular diseases as a result of cellular,
structural and molecular dysfunctions within the sub-endothelial space. This review deals …

Background Atherosclerosis (AS) is a chronic arterial pathology and a leading cause of
vascular disease-related mortality. Fatty streaks in the arterial wall develop into …

Abstract Background Cardiovascular diseases (CVDs) prevalence has significantly
increased in the last decade and atherosclerosis development is the main trigger …

Arteriosclerosis (AS) presents a significant global health challenge, demanding innovative
therapeutic strategies. This review explores the potential of nanoparticles (NPs) and …

Atherosclerosis is a chronic inflammatory disease and hypercholesterolemia is a risk factor.
This study aims to compare the potency of lipopolysaccharide (LPS) and oxidized low …

Background Cardiovascular diseases have been considered the primary cause of disability
and death worldwide. Coronary artery calcium (CAC) is an important indicator of the severity …